Mary DiBiase

XFOR

Mary DiBiase serves as Chief Operating Officer at X4 Pharmaceuticals, Inc. (XFOR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

12 trades

$143.9K

Net Position

Net Seller

$143.9K

Companies Traded

XFOR

Active Period

Feb 2023 – Jan 2025

12 total trades

Most Recent

Sell XFOR

Jan 27, 2025 · $10.1K

Mary DiBiase's Insider Trading at X4 Pharmaceuticals, Inc. (XFOR)

Buys

0 · $0.00

Sells

12 · $143.9K

Total Shares Bought

Total Shares Sold

206,742

XFOR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 27, 2025	Sell	22,258	$0.45	$10.1K	490,980
Oct 8, 2024	Sell	67,695	$0.57	$38.3K	452,060
Sep 11, 2024	Sell	2,642	$0.66	$1.7K	289,110
Mar 11, 2024	Sell	15,409	$0.88	$13.6K	291,752
Feb 12, 2024	Sell	3,683	$1.01	$3.7K	307,161
Nov 3, 2023	Sell	67,695	$0.73	$49.4K	310,844
Sep 12, 2023	Sell	2,642	$1.25	$3.3K	147,894
Jul 5, 2023	Sell	464	$1.89	$876.96	150,536
Jun 26, 2023	Sell	857	$1.93	$1.7K	151,000
Jun 16, 2023	Sell	857	$2.23	$1.9K	151,857
Mar 13, 2023	Sell	18,192	$0.84	$15.3K	152,714
Feb 15, 2023	Sell	4,348	$0.93	$4.0K	170,906

Related Insiders

Adam R Craig

Executive Chairman

XFORBuy · Oct 23, 2025

Mark Baldry

Chief Commercial Officer

XFORBuy · May 16, 2025

Explore More Insider Trading Data

XFOR Insider Trading Activity

View all insider trades at X4 Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity